Clinical Trial

Cancer of the Lung And SeneScencE - Prospective Cohort 1

Study acronym: CLASSE-P1
Recruiting
View on ClinicalTrials.gov →
Summary
The main objective is to identify and assess the predictive value of ageing and senescence biomarkers (methylome, telomeres, inflammageing) and senescent cells in tissues to improve prognosis assessment older patients with locally or locally-advanced Non-Small Cell Lung Cancer (NSCLC).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-04-04; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2025-07-16
Trial Details
NCT Number NCT06923618
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: ARC Foundation and Inserm, URC-CIC Paris Descartes Necker Cochin
Conditions Non-Small Cell Lung Cancer
Enrollment 385 participants
Start Date 2025-07-09
Primary Completion 2028-07 (estimated)
Study Completion 2032-07 (estimated)
Updated on ClinicalTrials.gov 2025-12-15